<?xml version="1.0" encoding="UTF-8"?><rss version="2.0" xmlns:content="http://purl.org/rss/1.0/modules/content/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:atom="http://www.w3.org/2005/Atom" xmlns:sy="http://purl.org/rss/1.0/modules/syndication/" > <channel> <title> Comments on: A Tough Road: Cost To Develop One New Drug Is $2.6 Billion; Approval Rate for Drugs Entering Clinical Development is Less Than 12% </title> <atom:link href="https://www.policymed.com/2014/12/a-tough-road-cost-to-develop-one-new-drug-is-26-billion-approval-rate-for-drugs-entering-clinical-de.html/feed" rel="self" type="application/rss+xml" /> <link>https://www.policymed.com/2014/12/a-tough-road-cost-to-develop-one-new-drug-is-26-billion-approval-rate-for-drugs-entering-clinical-de.html</link> <description>Legal, Regulatory, and Compliance Issues</description> <lastBuildDate>Thu, 21 Mar 2019 17:24:11 +0000</lastBuildDate> <sy:updatePeriod> hourly </sy:updatePeriod> <sy:updateFrequency> 1 </sy:updateFrequency> <item> <title> By: State of the Union and Healthcare Reform Proposals | Musings, Thoughts, Opinions </title> <link>https://www.policymed.com/2014/12/a-tough-road-cost-to-develop-one-new-drug-is-26-billion-approval-rate-for-drugs-entering-clinical-de.html#comment-82017</link> <dc:creator><![CDATA[State of the Union and Healthcare Reform Proposals | Musings, Thoughts, Opinions]]></dc:creator> <pubDate>Wed, 06 Feb 2019 16:40:06 +0000</pubDate> <guid isPermaLink="false">http://www.policymed.com/a-tough-road-cost-to-develop-one-new-drug-is-26-billion-approval-rate-for-drugs-entering-clinical-de/#comment-82017</guid> <description><![CDATA[[…] Rate for Drugs Entering Clinical Development is Less than 12%. May 6, 2018. Policy & Medicine. https://www.policymed.com/2014/12/a-tough-road-cost-to-develop-one-new-drug-is-26-billion-approval-r…. Accessed February 6, […]]]></description> <content:encoded><![CDATA[<p>[…] Rate for Drugs Entering Clinical Development is Less than 12%. May 6, 2018. Policy & Medicine. <a href="https://www.policymed.com/2014/12/a-tough-road-cost-to-develop-one-new-drug-is-26-billion-approval-r&#8230" rel="ugc">https://www.policymed.com/2014/12/a-tough-road-cost-to-develop-one-new-drug-is-26-billion-approval-r&#8230</a>;. Accessed February 6, […]</p> ]]></content:encoded> </item> <item> <title> By: Snubbed Medical Marijuana Super Bowl Ad Not Accurate Of Where U.S. Is Headed With Legalization – Norma Pence </title> <link>https://www.policymed.com/2014/12/a-tough-road-cost-to-develop-one-new-drug-is-26-billion-approval-rate-for-drugs-entering-clinical-de.html#comment-81976</link> <dc:creator><![CDATA[Snubbed Medical Marijuana Super Bowl Ad Not Accurate Of Where U.S. Is Headed With Legalization – Norma Pence]]></dc:creator> <pubDate>Sun, 27 Jan 2019 19:46:52 +0000</pubDate> <guid isPermaLink="false">http://www.policymed.com/a-tough-road-cost-to-develop-one-new-drug-is-26-billion-approval-rate-for-drugs-entering-clinical-de/#comment-81976</guid> <description><![CDATA[[…] only after the company endured years of research and clinical trials. Money was also a factor. Some data shows that it can cost a drug company billions of dollars to bring a medicinal product to market. […]]]></description> <content:encoded><![CDATA[<p>[…] only after the company endured years of research and clinical trials. Money was also a factor. Some data shows that it can cost a drug company billions of dollars to bring a medicinal product to market. […]</p> ]]></content:encoded> </item> <item> <title> By: Snubbed Medical Marijuana Super Bowl Ad Not Accurate Of Where U.S. Is Headed With Legalization – Susan Duggan </title> <link>https://www.policymed.com/2014/12/a-tough-road-cost-to-develop-one-new-drug-is-26-billion-approval-rate-for-drugs-entering-clinical-de.html#comment-81975</link> <dc:creator><![CDATA[Snubbed Medical Marijuana Super Bowl Ad Not Accurate Of Where U.S. Is Headed With Legalization – Susan Duggan]]></dc:creator> <pubDate>Sun, 27 Jan 2019 19:42:35 +0000</pubDate> <guid isPermaLink="false">http://www.policymed.com/a-tough-road-cost-to-develop-one-new-drug-is-26-billion-approval-rate-for-drugs-entering-clinical-de/#comment-81975</guid> <description><![CDATA[[…] only after the company endured years of research and clinical trials. Money was also a factor. Some data shows that it can cost a drug company billions of dollars to bring a medicinal product to market. […]]]></description> <content:encoded><![CDATA[<p>[…] only after the company endured years of research and clinical trials. Money was also a factor. Some data shows that it can cost a drug company billions of dollars to bring a medicinal product to market. […]</p> ]]></content:encoded> </item> </channel> </rss>